India  

No evidence of benefit for chloroquine and hydroxychloroquine in COVID-19 patients, study finds

Science Daily Friday, 22 May 2020 ()
A new study finds that the use of chloroquine or hydroxychloroquine is linked to increased rates of mortality and heart arrhythmias among hospital patients with COVID-19. The authors suggest that these drug regimens should not be used to treat COVID-19 outside of clinical trials and urgent confirmation from randomised clinical trials is needed.
0
shares
ShareTweetSavePostSend
 
Credit: Wochit - Published
News video: Chloroquine And Hydroxychloroquine Could Pose Higher COVID-19 Death Risk

Chloroquine And Hydroxychloroquine Could Pose Higher COVID-19 Death Risk 00:35

According to UPI, chloroquine and hydroxychloroquine has no clinical benefit for people with COVID-19. A study published in The Lancet on Friday says that the drugs might actually cause serious heart-related side effects. The study of 15,000 patients found increased rate of heart-related side...

You Might Like


Recent related videos from verified sources

Large Scale UK Study Highlights Major Risk Factors In Dying From COVID-19 [Video]

Large Scale UK Study Highlights Major Risk Factors In Dying From COVID-19

The results of the largest study to date of coronavirus patients outside China was published Friday. According to Business Insider, researchers analyzed data from 20,133 patients hospitalized across..

Credit: Wochit     Duration: 00:35Published
Large study finds hydroxychloroquine COVID-19 treatments linked to greater risk of death and heart arrhythmia [Video]

Large study finds hydroxychloroquine COVID-19 treatments linked to greater risk of death and heart arrhythmia

A new study looking at hydroxychloroquine has found that COVID-19 patients who were treated with the drug faced a higher risk of death. And they were also more likely to develop serious irregular heart..

Credit: WXYZ Detroit     Duration: 03:38Published

Recent related news from verified sources

No evidence of benefit for chloroquine, hydroxychloroquine in Covid-19 patients, urgent randomised trials needed: Lancet


Indian Express Also reported by •Reuters India

Donated plasma benefits COVID-19 patients in small U.S. study

Patients with severe COVID-19 given plasma from someone who recovered from the disease were more likely to stabilize or need less oxygen support than other...
Reuters India


Tweets about this

GoumasUrologia

Goumas Urologia RT @TheLancet: NEW Research—No evidence of benefit for #chloroquine and #hydroxychloroquine in #COVID19 patients, urgent randomised trials… 1 minute ago

unnikrishnansun

UnniKrishnan R Santoish The Lancet: No evidence of benefit for chloroquine and hydroxychloroquine in COVID-19 patients https://t.co/YYivwG7hUn 25 minutes ago

unnikrishnansun

UnniKrishnan R Santoish @MBRajeshCPM The Lancet: No evidence of benefit for chloroquine and hydroxychloroquine in COVID-19 patients. The st… https://t.co/MsoAVacQ67 29 minutes ago